Not Considering Roping In An Investor Or Listing Of Consumer Health Biz: Mankind Pharma | CNBC TV18

Not Considering Roping In An Investor Or Listing Of Consumer Health Biz: Mankind Pharma | CNBC TV18

CNBC-TV18 LIVE | Mankind Pharma Listing TodayПодробнее

CNBC-TV18 LIVE | Mankind Pharma Listing Today

Market Is Battling Valuations Right Now & Investors Need To Be Careful: Quantum Advisors | CNBC TV18Подробнее

Market Is Battling Valuations Right Now & Investors Need To Be Careful: Quantum Advisors | CNBC TV18

Stellar Listing For Mankind Pharma; Debuts At 20% Premium To Issue Price | Trading Hour | CNBC-TV18Подробнее

Stellar Listing For Mankind Pharma; Debuts At 20% Premium To Issue Price | Trading Hour | CNBC-TV18

Mankind Pharma Board Meets Today To Discuss Fundraise For BSV Acquisition & Future Growth PlansПодробнее

Mankind Pharma Board Meets Today To Discuss Fundraise For BSV Acquisition & Future Growth Plans

Mankind Pharma To File DRHP For IPO Shortly, Sources Say | Trading Hour | CNBC-TV18Подробнее

Mankind Pharma To File DRHP For IPO Shortly, Sources Say | Trading Hour | CNBC-TV18

Mankind Pharma Makes A Stellar Market Debut, Shares List At 20% Premium | Bazaar Corporate RadarПодробнее

Mankind Pharma Makes A Stellar Market Debut, Shares List At 20% Premium | Bazaar Corporate Radar

Mankind Pharma rises 23% on listing debut | Latest World News | English News | WIONПодробнее

Mankind Pharma rises 23% on listing debut | Latest World News | English News | WION

Mankind Pharma ₹ 4,300 Crore IPO Opens Today, VC & MD Rajeev Juneja On This & More | CNBC-TV18Подробнее

Mankind Pharma ₹ 4,300 Crore IPO Opens Today, VC & MD Rajeev Juneja On This & More | CNBC-TV18

More Trouble for Go First & SpiceJet, Stellar Listing for Mankind Pharma & More | CNBC-TV18Подробнее

More Trouble for Go First & SpiceJet, Stellar Listing for Mankind Pharma & More | CNBC-TV18

Experts On What One Should Know Before Investing In Thematic Funds | Let's Talk Money | CNBC TV18Подробнее

Experts On What One Should Know Before Investing In Thematic Funds | Let's Talk Money | CNBC TV18

Mankind Pharma IPO To Open On April 25, Will Continue To Be India Centric, Says Rajeev JunejaПодробнее

Mankind Pharma IPO To Open On April 25, Will Continue To Be India Centric, Says Rajeev Juneja

Mankind Pharma files for IPO, could be second largest among pharma firmsПодробнее

Mankind Pharma files for IPO, could be second largest among pharma firms

Brokerages Weigh Impact Of US Court's Patent Decision On Zydus Life, Lupin | CNBC TV18Подробнее

Brokerages Weigh Impact Of US Court's Patent Decision On Zydus Life, Lupin | CNBC TV18

Shilpa Medicare, Max Health & Concord Biotech Rally On Positive Brokerage Notes | CNBC TV18Подробнее

Shilpa Medicare, Max Health & Concord Biotech Rally On Positive Brokerage Notes | CNBC TV18

Want To Enter Niche Products In The Export Market: Mankind Pharma | CNBC TV18Подробнее

Want To Enter Niche Products In The Export Market: Mankind Pharma | CNBC TV18

No Further Stake Sale Is Expected By Promoters: Mankind Pharma | CNBC TV18Подробнее

No Further Stake Sale Is Expected By Promoters: Mankind Pharma | CNBC TV18

PE Investments Rising In Healthcare In India. Attracts Rs 27,000 Cr In 2 Years | CNBC TV18Подробнее

PE Investments Rising In Healthcare In India. Attracts Rs 27,000 Cr In 2 Years | CNBC TV18

IIFL & Axis Cap Bullish On The Recently-Listed Pharma Player | CNBC TV18Подробнее

IIFL & Axis Cap Bullish On The Recently-Listed Pharma Player | CNBC TV18

Mankind Pharma Gains In Trade, The Stock Has Doubled Since Listing In May 2023 | CNBC TV18Подробнее

Mankind Pharma Gains In Trade, The Stock Has Doubled Since Listing In May 2023 | CNBC TV18